Ticker Details
ALX Oncology Holdings Inc.
IPO Date:	July 17, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$285.95M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.78 | 4.50%
Avg Daily Range (30 D):	$0.10 | 5.62%
Avg Daily Range (90 D):	$0.08 | 4.30%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	1.26M
Avg Daily Volume (90 D):	.95M

Trade Size
Avg Trade Size (Sh.):	117
Avg Trade Size (Sh.) (30 D):	158
Avg Trade Size (Sh.) (90 D):	153

Institutional Trades
Total Institutional Trades:	855
Avg Institutional Trade:	$1.84M
Avg Institutional Trade (30 D):	$2.73M
Avg Institutional Trade (90 D):	$1.95M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.99M
Avg Closing Trade (30 D):	$8.54M
Avg Closing Trade (90 D):	$3.3M
Avg Closing Volume:	122.55K

News

Feb 27, 2026 @ 1:00 PM ALX Oncology Reports Fourth Quarter and Full Year ... Source: Alx Oncology Holdings Inc.

Jan 8, 2026 @ 4:00 PM ALX Oncology to Present at the 44th Annual J.P. Mo... Source: Alx Oncology Holdings Inc.

Dec 7, 2025 @ 1:00 PM ALX Oncology Announces Positive Results from Ongoi... Source: Alx Oncology Holdings Inc.

Nov 27, 2025 @ 6:00 PM HER2-positive Gastric Cancer Clinical Trial Pipeli... Source: Delveinsight

Nov 18, 2025 @ 4:00 PM ALX Oncology to Present at Upcoming Investor Confe... Source: Alx Oncology Holdings Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.17	$-.42	$-1.9
Diluted EPS	$-.17	$-.42	$-1.9
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-17.93M	$-22.85M	$-101.7M
Operating Income / Loss	$-18.97M	$-23.02M	$-104.02M
Cost of Revenue
Net Cash Flow	$15.91M	$-7.07M	$-1.19M
PE Ratio